Eugene Storozynsky

604 total citations
33 papers, 453 citations indexed

About

Eugene Storozynsky is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Biomedical Engineering. According to data from OpenAlex, Eugene Storozynsky has authored 33 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Oncology and 10 papers in Biomedical Engineering. Recurrent topics in Eugene Storozynsky's work include Mechanical Circulatory Support Devices (9 papers), Cardiac Structural Anomalies and Repair (7 papers) and Cardiac Arrest and Resuscitation (5 papers). Eugene Storozynsky is often cited by papers focused on Mechanical Circulatory Support Devices (9 papers), Cardiac Structural Anomalies and Repair (7 papers) and Cardiac Arrest and Resuscitation (5 papers). Eugene Storozynsky collaborates with scholars based in United States, Canada and France. Eugene Storozynsky's co-authors include Diwakar Jain, Ronald G. Schwartz, John G. Frelinger, Edith M. Lord, Hella Stössel, William J. Swiggard, Joshua P. Metlay, Paul Freimuth, Margit D. Witmer-Pack and Ralph M. Steinman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Eugene Storozynsky

28 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Storozynsky United States 11 167 134 113 73 68 33 453
George D. Soufras Greece 11 141 0.8× 80 0.6× 61 0.5× 25 0.3× 80 1.2× 35 416
Michael R. King United States 13 87 0.5× 71 0.5× 59 0.5× 9 0.1× 177 2.6× 36 527
F. B. Lewis United States 11 90 0.5× 62 0.5× 41 0.4× 87 1.2× 43 0.6× 19 371
Yael Bar‐On Israel 12 31 0.2× 81 0.6× 180 1.6× 27 0.4× 10 0.1× 26 502
Péter Fritz Canada 11 20 0.1× 46 0.3× 70 0.6× 45 0.6× 51 0.8× 22 375
William R. Critchley United Kingdom 11 99 0.6× 28 0.2× 35 0.3× 11 0.2× 256 3.8× 35 411
M. Witvliet Netherlands 12 49 0.3× 109 0.8× 20 0.2× 13 0.2× 208 3.1× 21 520
Friedrich Erhart Austria 10 34 0.2× 67 0.5× 60 0.5× 14 0.2× 21 0.3× 19 281

Countries citing papers authored by Eugene Storozynsky

Since Specialization
Citations

This map shows the geographic impact of Eugene Storozynsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Storozynsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Storozynsky more than expected).

Fields of papers citing papers by Eugene Storozynsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Storozynsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Storozynsky. The network helps show where Eugene Storozynsky may publish in the future.

Co-authorship network of co-authors of Eugene Storozynsky

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Storozynsky. A scholar is included among the top collaborators of Eugene Storozynsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Storozynsky. Eugene Storozynsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber, Matthew P., Eugene Storozynsky, Howard J. Eisen, et al.. (2025). Trends in Left Ventricular Assist Device Utilization and Survival Outcomes Following the Donor Allocation Policy Change. Artificial Organs.
2.
Filicko-O’Hara, Joanne, et al.. (2025). The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 32(1). 65–73.
3.
Choi, Wookjin, Jennifer Kwak, Maria Werner‐Wasik, et al.. (2024). Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clinical Cancer Informatics. 8(8). e2300241–e2300241. 3 indexed citations
4.
Patel, Amar, et al.. (2024). The Good (Tumor Killing) and the Bad (Cardiovascular Complications) of Immunologic Checkpoint Inhibitors. Current Cardiology Reports. 26(12). 1487–1498. 1 indexed citations
5.
Sherazi, Saadia, Scott McNitt, Carla Casulo, et al.. (2023). Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders. Journal of the American Heart Association. 12(6). e025786–e025786. 1 indexed citations
6.
Storozynsky, Eugene, et al.. (2022). A CASE OF CARDIAC SARCOIDOSIS UNMASKED BY NIVOLUMAB. Journal of the American College of Cardiology. 79(9). 2655–2655.
7.
Irabor, Omoruyi Credit, Nicolas G. Nelson, Yash Shah, et al.. (2022). Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. Frontiers in Oncology. 12. 940127–940127. 7 indexed citations
8.
Arcoleo, Kimberly, et al.. (2021). Reported Signs, Symptoms, and Diagnostic Tests Before Cardiotoxicity Among Women With Breast Cancer: A Pilot Study. The Journal of Cardiovascular Nursing. 37(2). 104–111. 1 indexed citations
9.
Ayers, Brian, Katherine Wood, Bryan Barrus, et al.. (2019). Extracorporeal life support to ventricular assist device: potential benefits of sternal-sparing approach. Journal of Thoracic Disease. 11(11). 4790–4797. 4 indexed citations
10.
Schaffer, Kerry, Kah Poh Loh, Ian R. Kleckner, et al.. (2019). Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer. Journal of the National Comprehensive Cancer Network. 17(1). 57–63. 53 indexed citations
11.
Schaffer, Kerry, Kah Poh Loh, Ian R. Kleckner, et al.. (2018). A systematic review of randomized controlled trials (RCTs) of exercise interventions using digital activity trackers (E-DAT) in cancer patients.. Journal of Clinical Oncology. 36(7_suppl). 108–108. 3 indexed citations
12.
Russell, Raymond R., J. Steven Alexander, Diwakar Jain, et al.. (2016). The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy. Journal of Nuclear Cardiology. 23(4). 856–884. 39 indexed citations
13.
Storozynsky, Eugene. (2015). Multimodality Assessment and Treatment of chemotherapy-induced Cardiotoxicity. Future Cardiology. 11(4). 421–424. 2 indexed citations
14.
Schwartz, Ronald G., Diwakar Jain, & Eugene Storozynsky. (2013). Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively. Journal of Nuclear Cardiology. 20(3). 443–464. 67 indexed citations
15.
Kakinami, Lisa, et al.. (2011). Review of Ambulatory Pulmonary Artery Catheterization in the Management of Advanced Heart Failure. Congestive Heart Failure. 18(3). 173–178. 1 indexed citations
16.
Storozynsky, Eugene, et al.. (2010). Renin Inhibition for Hypertension: Selecting the Right Role for a New Class of Drug. American Journal of Therapeutics. 17(2). 182–187. 2 indexed citations
17.
Storozynsky, Eugene, et al.. (2009). Baroreflex device therapy in the treatment of hypertension. Current Hypertension Reports. 11(1). 69–75. 15 indexed citations
18.
19.
Lord, Edith M., et al.. (1998). IL-3-Mediated Enhancement of Particulate Antigen Presentation by Macrophages. Journal of Immunotherapy. 21(3). 205–210. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George D. Soufras Breakdown of academic impact, for papers by Michael R. King Breakdown of academic impact, for papers by F. B. Lewis Breakdown of academic impact, for papers by Yael Bar‐On Breakdown of academic impact, for papers by Péter Fritz Breakdown of academic impact, for papers by William R. Critchley Breakdown of academic impact, for papers by M. Witvliet Breakdown of academic impact, for papers by Friedrich Erhart
Rankless by CCL
2026